Mepivacaine HCl
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 282.81 |
| Cas No. | 1722-62-9 |
| Formula | C15H22N2O·HCl |
| Solubility | ≥10.2 mg/mL in EtOH with ultrasonic; ≥24.2 mg/mL in DMSO; ≥5.8 mg/mL in H2O |
| Chemical Name | N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride |
| SDF | Download SDF |
| Canonical SMILES | CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
| Animal experiment [1]: | |
|
Animal models |
Canis familiaris |
|
Dosage form |
0.514 and 1.542 mg/kg (intraoral infiltrative administration of 2% mepivacaine HCl with 1:20,000 levonordefrin) |
|
Application |
Cardiovascular alterations (increase in the systolic and the mean arterial blood pressures) caused by the administration of 2% mepivacaine HCl with 1:20,000 levonordefrin (Carbocain) in dogs. |
|
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
|
References: [1] Simone JL, Tortamano N, Armonia PL, Rocha RG. Cardiovascular alterations caused by the administration of 2% mepivacaine HCl with 1:20,000 levonordefrin (Carbocain) in dogs. Braz Dent J. 1997;8(2):85-90. | |
Quality Control & MSDS
- View current batch:
Chemical structure
